A test for the virus that causes cervical cancer can replace the annual Pap smear for many women experts say The advisers to the Food and Drug Administration recommend that the agency allow the tests maker to market it as a firstline screening tool for cervical cancer which kills more than  US women every year The test looks for evidence of human papillomavirus HPV which causes not only cervical cancer but cancer of the mouth throat penis and other areas Women with evidence of active HPV infection could then be given a Pap test which is examined for evidence of cancerous or precancerous cells If approved the cobas HPV Test would become the first and only HPV test indicated as the firstline primary screen of cervical cancer in the United States Roche the company that makes the test said in a statement Researchers that for women  and over an HPV test is better than a Pap smear for predicting cervical cancer risk and those who test negative on both can safely wait three years to be screened again HPV is extremely common The Centers for Disease Control and Prevention estimates that  million Americans are currently infected with HPV Another  million people become newly infected each year For most the virus clears their system on its own but at least  percent of sexually active men and women are infected at some point in their lives Some estimates range as high as  percent Cervical cancer kills more than  women a year in the United States and  globally There are   Mercks Gardasil and its rival GlaxoSmithKlines Cervarix The Pap test can find evidence of cervical cancer which is very slowgrowing before it even becomes truly cancer Doctors can remove the damaged cells But most cases are caused by HPV and studies suggest that an HPV test is more accurate than a Pap The US Preventive Services Task Force  can go as long as five years between cervical cancer screenings as long as they make sure to get both a Pap smear and an HPV test when they do get examined